UNC Chapel Hill pairs research expertise with industry needs: a shorter road from ideas to the marketplace.

PositionRESEARCH NORTH CAROLINA: UNC CHAPEL HILL

In 2015, UNC Chapel Hill joined the ranks of the top 10 U.S. research universities, thanks to a diverse portfolio of nearly $1 billion annually. Global industry leaders like GlaxoSmithKline, Cisco Systems, and Eastman Chemical have taken notice and forged novel partnerships with UNC scientists.

Faculty and students come to UNC for its global reputation, cutting-edge research, and culture of collaboration. That atmosphere extends off-campus to private companies who seek expertise to bring down diseases and develop solutions to complex technological challenges. Industry funding for UNC research jumped 14% from 2013 to 2014, reaching $36.9 million, a number UNC aims to rapidly increase.

* To end an evil disease

Since UNC Hospitals treated its first AIDS patient in 1981, the university has been a leader in HIV research. In 2011, a global, UNC-led study demonstrated that early treatment with antiretrovirals can massively reduce the spread of HIV. UNC's preeminence in HIV research led to the announcement in 2015 of an unprecedented UNC partnership with GlaxoSmithKline to end the disease once and for all.

The new HIV Cure Center at UNC will focus exclusively on a cure for HIV/AIDS. Qura Therapeutics, jointly owned by the university and GSK, will handle the partnership's business and intellectual property.

GSK will invest $20 million each year and embed a team of researchers at the center. UNC will contribute world-class lab space, access to patients and funding, and faculty research expertise. "This first of its kind, joint-ownership model is a novel approach toward finding a cure," says Chancellor Carol L. Folt. "We hope it serves as an invitation to the world's best researchers and scientists."

* A research partner for N.C. business

As UNC's research rankings have climbed, it has strengthened relationships with N.C. companies such as Quintiles and helped draw businesses like Eastman Chemical to the state. UNC routinely partners with Quintiles, sharing clinical trials, fellowships, and knowledge for best practices. UNC's chemistry, physics, and applied physical sciences departments work closely with Eastman, which has funded more than $2 million of research at UNC.

Later this summer, UNC will launch a new Office of Industry Contracting. This central resource will reduce contract cycle times and simplify the process for more industry partners to connect with UNC researchers.

UNC specializes in training students in fields central to North...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT